Pubdate: Fri, 26 Jan 2001 Source: Idaho State Journal (ID) Copyright: 2001 Idaho State Journal Contact: PO Box 431, Pocatello ID 83204 Fax: 208-233-8007 Website: http://www.journalnet.com/ Author: Robert Sharpe SENSIBLE SOLUTIONS FOR DRUGS Regarding the excellent Jan. 21st editorial on drug policy, there are cost-effective alternatives to the drug war. The current approach is counterproductive. Numerous studies have found that prison transmits violent habits rather than reduces them. Most non-violent drug offenders are eventually released, with dismal job prospects due to criminal records. Rather than waste resources turning potentially productive members of society who use drugs into hardened criminals, we should be funding cost-effective treatment. At an average cost of $25,071 per inmate annually, maintaining the world's largest prison system can hardly be considered fiscally conservative. As far as organized crime is concerned, alcohol was very much associated with organized crime until Prohibition was repealed in 1933. With no controls for age, the thriving black market is very much youth-oriented. Sensible regulation is desperately needed to undermine the black market and restrict access to drugs. As counterintuitive as it may seem, replacing marijuana prohibition with regulation would do a better job protecting children than the drug war. Compared to legal alcohol, marijuana is relatively harmless. Yet marijuana prohibition is deadly. Although there is nothing inherent in marijuana that compels users to try hard drugs like meth, its black market status puts users in contact with criminals who push them. Current drug policy is effectively a gateway policy. In Europe, the Netherlands has managed to greatly reduce overall drug use by separating the hard and soft drug markets and establishing controls for age. Unfortunately for Americans, our leaders are more prone to preaching than pragmatism. Robert Sharpe, M.P.A. program officer The Lindesmith Center-Drug Policy Foundation, Washington, DC - --- MAP posted-by: Keith Brilhart